| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/07/2010 | CA2727365A1 Method for diagnosing cancers expressing the her2 receptor or its truncated variants |
| 01/06/2010 | EP2141243A2 Protein scaffolds for antibody mimics and other binding proteins |
| 01/06/2010 | EP2141237A1 Method for reducing the fucose content of recombinant proteins |
| 01/06/2010 | EP2141235A1 Adiponectin receptor and gene coding for the same |
| 01/06/2010 | EP2141232A1 Polyamino acid synthetase and gene encoding the same |
| 01/06/2010 | EP2141180A1 Antibody recognizing canine CRP and human CRP |
| 01/06/2010 | EP2140881A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 01/06/2010 | EP2139994A2 2786, a human aminopeptidase |
| 01/06/2010 | EP2139924A1 Bispecific antibodies and methods for production thereof |
| 01/06/2010 | EP2139923A1 Modulation of tumor microenvironment |
| 01/06/2010 | EP2139922A1 Treatment of hodgkins lymphoma |
| 01/06/2010 | EP2139920A1 Human anti cd166 antibody binding human tumor cells |
| 01/06/2010 | EP2139919A2 Human anti-ip-10 antibodies and uses thereof |
| 01/06/2010 | EP2139918A2 Antibody single variable domains against serum albumin |
| 01/06/2010 | EP2139917A2 Anti-androgen peptides and uses thereof in cancer therapy |
| 01/06/2010 | EP2139916A1 Toll-like receptor binding epitope and compositions for binding thereto |
| 01/06/2010 | EP1461073B1 Peptide agonists of prostate-specific antigen, and uses therefor |
| 01/06/2010 | EP1409018B1 Stable lyophilized pharmaceutical formulation the igg antibody daclizumab |
| 01/06/2010 | CN101622276A Antagonist antibody against EPHA2 for the treatment of cancer |
| 01/06/2010 | CN101622275A Method of providing disease-specific binding molecules and targets |
| 01/06/2010 | CN100577809C Enzymes having alpha amylase activity and method of use thereof |
| 01/06/2010 | CN100577804C Novel mutant allergens |
| 01/05/2010 | US7643943 Methods for monitoring drug activities in vivo |
| 01/05/2010 | US7642345 Polynucleotides encoding human cytokine receptor |
| 01/05/2010 | US7642342 Generate immune response by activation of a T cell or a B cell to claimed peptide, nucleotide expressed in a viral vector; vaccinia, fowlpox, canarypox, adenovirus, influenza, poliovirus, adeno-associated virus, lentivirus, Sindbis virus; diagnostic and therapeutic applications |
| 01/05/2010 | US7642341 Antibody fragments are selected from Fab fragments, Fv fragments, single domain antigen binding fragments, scFv and aggregates thereof; for treatment of solid tumor carcinomas |
| 01/05/2010 | US7642238 Using soluble frizzled related protein 3 (SFRP-3) and/or Dickkopf-1 (DKK1) expression profiles as evaluative tools in prediciting/diagnosing bone disorders in cancer patients |
| 01/05/2010 | US7642235 Macrocyclic peptides active against the hepatitis C virus |
| 01/05/2010 | US7642230 precipitation, freeze drying; for increasing leukocytes; pharmacokinetics |
| 01/05/2010 | US7642228 Method for making heteromultimeric polypeptides |
| 01/05/2010 | US7642054 "STRAP" and "STEAP" (six transmembrane epithelial antigen of the prostate) |
| 01/05/2010 | US7642045 Antibodies to protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells |
| 01/05/2010 | US7642044 Trimerising module |
| 01/05/2010 | US7641910 Amino acid sequence or immunogenic fragment of at least 15 contiguous amino acid sequence when administered to a subject induce antibody or T-cell mediated immune response that recognizes polypeptide |
| 01/05/2010 | US7641905 Methods of inducing an immune response |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | US7641899 Methods for inhibiting IL-TIF-induced proliferation of hematopoietic cells using the cytokine receptor Zcytor16 |
| 01/05/2010 | US7641891 Chimeric, human and humanized anti-CSAp monoclonal antibodies |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 01/05/2010 | CA2281877C Psca: prostate stem cell antigen |
| 01/05/2010 | CA2164835C Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 01/05/2010 | CA2062763C Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
| 12/31/2009 | US20090328255 Nitrogen limitation adaptability gene and protein and modulation thereof |
| 12/31/2009 | US20090327170 Methods of Clustering Gene and Protein Sequences |
| 12/31/2009 | US20090326614 Shape Tunable Plasmonic Nanoparticles |
| 12/31/2009 | US20090326206 Single-chain Multiple Antigen-binding Molecule, Its Preparation and Use |
| 12/31/2009 | US20090326205 ANTI-HUMAN Dlk-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO |
| 12/31/2009 | US20090326204 Interferon-like protein zcyto21 |
| 12/31/2009 | US20090326203 Framework Selection |
| 12/31/2009 | US20090326202 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 12/31/2009 | US20090325880 Tnf receptor-like molecules and uses thereof |
| 12/31/2009 | US20090325873 Human glp-1 mimetibodies, compositions, methods and uses |
| 12/31/2009 | US20090325815 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 12/31/2009 | US20090325312 Reagens for the detection of protein acetylation signaling pathways |
| 12/31/2009 | US20090325290 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
| 12/31/2009 | US20090325259 Use of adhesion molecules as bond stress-enhanced nanoscale binding switches |
| 12/31/2009 | US20090325196 Levels of bcma protein expression on b cells and use in diagnostic methods |
| 12/31/2009 | US20090325195 Polyclonal-monoclonal elisa assay for detecting n-terminus pro-bnp |
| 12/31/2009 | US20090325189 Tyrosine phosphorylation sites |
| 12/31/2009 | US20090325187 Immunomodulation |
| 12/31/2009 | US20090325174 Rapid, Sensitive and Quantitative Methods for Tissue and Cell-Based Proteomics via Consecutive Addition of Quantifiable Extenders |
| 12/31/2009 | US20090324723 Method of prophylaxis of infection |
| 12/31/2009 | US20090324707 Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines |
| 12/31/2009 | US20090324649 Leishmania vaccine using sand fly salivary immunogen |
| 12/31/2009 | US20090324622 Antibody vaccine conjugates and uses therefor |
| 12/31/2009 | US20090324621 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 12/31/2009 | US20090324620 Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
| 12/31/2009 | US20090324619 Immunogenic Protein Carrier Containing An Antigen Presenting Cell Binding Domain and A Cysteine-Rich Domain |
| 12/31/2009 | US20090324614 Fc receptor binding proteins |
| 12/31/2009 | US20090324613 Compositions and Methods for the Therapy and Diagnosis of Cytomegalovirus |
| 12/31/2009 | US20090324608 Novel human protein kinase, phosphatase, and protease family members and uses thereof |
| 12/31/2009 | US20090324606 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 12/31/2009 | US20090324605 Interferon alpha antibodies and their uses |
| 12/31/2009 | US20090324604 M-csf specific monoclonal antibody and uses thereof |
| 12/31/2009 | US20090324603 Met fab and scfv fragments and methods of use |
| 12/31/2009 | US20090324602 Anti-fn14 antibodies and uses thereof |
| 12/31/2009 | US20090324601 Targeted binding agents directed to pdgfr-alpha and uses thereof |
| 12/31/2009 | US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 12/31/2009 | US20090324598 Method for the treatment of inflammatory disorders |
| 12/31/2009 | US20090324597 Unique long 16 (UL-16)-binding proteins (ULBP) specific immunoglobulin for use in diganosis cell proliferative disorders |
| 12/31/2009 | US20090324593 Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof |
| 12/31/2009 | US20090324592 Compositions and methods for the diagnosis and treatment of tumor |
| 12/31/2009 | US20090324590 Myostatin antagonists |
| 12/31/2009 | US20090324589 Methods for controlling blood pharmacokinetics of antibodies |
| 12/31/2009 | US20090324588 Treating Inflammatory Disorders With Antibodies to the Alpha-7 Nicotinic Receptors |
| 12/31/2009 | US20090324579 Anti-apoptotic protein antibodies |
| 12/31/2009 | US20090324566 T-Cell Receptor and Nucliec Acid Encoding the Receptor |
| 12/31/2009 | US20090324553 Chimeric Viral Envelopes |
| 12/31/2009 | US20090324549 Proteins and/or peptides for the prevention and/or treatment of neurodegenerative diseases |
| 12/31/2009 | US20090324512 Polypeptide constructs for nasal administration |
| 12/31/2009 | US20090324501 Vaccine Carrier |
| 12/31/2009 | US20090324492 Treatment for Central Nervous System Disorders |
| 12/31/2009 | US20090324491 Diagnosis and Treatment of Cancer Using Anti-EREG Antibody |
| 12/31/2009 | US20090324490 Compositions and methods for the diagnosis and treatment of tumor |
| 12/30/2009 | WO2009158658A2 Induction of flocculation in photosynthetic organisms |
| 12/30/2009 | WO2009158614A1 Novel astrovirus |
| 12/30/2009 | WO2009158432A2 Ang-2 inhibition to treat multiple sclerosis |
| 12/30/2009 | WO2009157771A2 Antibody producing non-human mammals |
| 12/30/2009 | WO2009157623A1 Cd9-specific human antibodies |
| 12/30/2009 | WO2009156179A1 Her3 as a determinant for the prognosis of melanoma |